GLP-1 Receptor Agonist Market Size The global GLP-1 receptor agonist market size was valued at USD 24.4 billion in 2023 and is expected to grow at 9.7% CAGR from 2024 to 2032, driven by rising incidences of type 2 diabetes and obesity globally
These peptides mimic natural hormone pathways to restore healthy HGH function without the risks of synthetic hormone therapy
Usually taken by self-administered injection, these medications mimic the action of the natural hormone GLP-1 (glucagon-like peptide-1), which is produced in the gut and plays important roles in appetite regulation and glucose metabolism
Oestrogen supplements in postmenopausal women can help prevent abdominal fat accumulation
Rather, it suggests those effects may be more subtleor harder to measurethan many people assume
That makes it a popular choice for people focused on body composition, muscle growth, and anti-aging goals